一种基于cereblon的NEK7降解剂调节NLRP3炎症组以一种上下文依赖的方式
Aude Sylvain1, Natacha Stoehr1, Fupeng Ma2
1Novartis Biomedical Research, Basel, Switzerland.
Cell chemical biology
|July 10, 2025
概括
新型降解剂NK7-902针对NEK7抑制NLRP3炎症酶途径. 虽然在小鼠中有效,但它对人类和子中的IL-1β释放的影响是可变的,这表明NEK7对NLRP3激活并不重要.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 异常激活NLRP3炎症酶与许多炎症性疾病有关.
- NEK7是一种关键蛋白质,可以调节NLRP3炎症酶组合和激活.
- 准NEK7为炎症条件提供了潜在的治疗策略.
研究的目的:
- 为了研究NK7-902的有效性,一个大脑 (CRBN) 粘合剂降解剂,在降低NEK7蛋白水平和抑制NLRP3炎症酶激活.
- 评估NEK7降解对人类,小鼠和非人类灵长类动物模型中的IL-1β释放的影响.
主要方法:
- 使用NK7-902,一个有选择性的CRBN粘合剂降解剂,针对NEK7.
- 评估了人类免疫细胞,全血细胞和小鼠细胞中的NEK7降解.
- 在体外和体内测量了跨物种的NLRP3依赖IL-1β释放.
- 将NK7-902口服给Cynomolgus子,以评估长期影响.
主要成果:
- 在人类和小鼠细胞中,NK7-902有效降解了NEK7.
- 在某些人类实验条件下,完整的NEK7降解仅部分抑制了IL-1β的释放.
- 在小鼠体内,NK7-902抑制了IL-1β的释放.
- 在Cynomolgus子中,NEK7降解是持久的,但IL-1β抑制是暂时的.
结论:
- 通过NK7-902降解NEK7显示在阻断NLRP3介导IL-1β释放方面具有特定物种的疗效.
- 在人类和非人类灵长类动物中,NEK7似乎有助于NLRP3的激活,但不是绝对必要的.
- 需要进一步的研究来了解NEK7在不同物种NLRP3炎症酶调节中的细微差别.
相关概念视频
Export of Misfolded Proteins out of the ER
3.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
Caspases
12.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.7K
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Necrosis
4.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K


